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Background: Colorectal cancer (CRC) survivors are at increased risk of developing the disease again. Surveillance
guidelines are aimed at maximising the early detection of recurring or new cancers and pre-cancerous polyps. The
frequency and type of surveillance recommended depends on the type of treatment for the initial CRC, the extent
of colonoscopic investigation prior to treatment and the results of previous surveillance tests. This paper aimed to
test the effect of a paper–based educational intervention to improve adherence to colonoscopy following
treatment for colorectal cancer.
Methods: People with a diagnosis of colorectal cancer within the last 10 months, aged ≥18 and English speaking
were recruited through a population-based cancer registry in Australia. Participants were randomly allocated to
either the intervention or control. Participants completed an interview at baseline. Self-reported participation in
colonoscopy was obtained at 12 month followup by survey. Those allocated to the control received a generic
pamphlet on colorectal cancer treatment; while intervention participants received a letter which provided specific
information about guideline recommendations for surveillance colonoscopy. Rates of guideline adherence were
compared between groups. The guideline recommendations for the timing of surveillance colonoscopy changed
part way through the study. This change occurred after all intervention materials had been sent, but prior to all
participants completing the 12 month follow up. Post hoc analyses were conducted to assess adherence to the
new guidelines.
Results: Of the 767 participants, 604 (79%) had had surgery, had stage I – III disease and completed the baseline
interview within 12 months of diagnosis (intervention = 305; control = 299). There was no significant difference
between those adherent to surveillance colonoscopy guidelines, in the control (67, 27%) and intervention groups
(80, 31%) at followup (difference = 4.3% (95%CI:-3.7%, 12%), χ2(1df) = 1.09, P = 0.296). Overall, 246 (49%) participants
were adherent to the new guidelines, compared to 147 (29%) adherent to the old guidelines.
Conclusions: Results indicate the paper-based educational intervention is not effective in improving adherence to
colorectal cancer surveillance guidelines for colonoscopy.
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Surveillance guideline recommendations
Colorectal cancer (CRC) survivors are at increased risk
of developing the disease again [1–3]. Surveillance
guidelines are aimed at maximising the early detection
of recurring or new cancers and pre-cancerous polyps
[3]. The frequency and type of surveillance recom-
mended depends on the type of treatment for the initial
CRC, the extent of colonoscopic investigation prior to
treatment and the results of previous surveillance tests.
In Australia, National Health and Medical Research
Council (NHMRC) guidelines released in 1999 [1] and
2005 [3] recommended that those who did not have a
colonoscopy when first diagnosed should have one 3–6
months after surgery then every 3–5 years. In December
2011 the guidelines specific to surveillance colonoscopy
[4] were updated to include a colonoscopy one year after
surgery unless a complete post-operative colonoscopy
has been performed previously.
Adherence to surveillance guideline recommendations
One Australian study indicated only 23% of surveillance
colonoscopies were in accordance with NHMRC recom-
mendations, with the screening interval shorter than
recommended in 70% of non-adherent cases [1, 5]. Simi-
larly, a study in the USA [6] found that around 30% of
CRC survivors had subsequent colonoscopies within two
years of a normal result, more frequently than is recom-
mended by guidelines. In contrast, another US study [7]
found that only 49% of CRC survivors received a colon-
oscopy within 14 months of surgery. Endoscopists’ rec-
ommendation for early follow up has been associated
with overuse of surveillance colonoscopy [8]. However
studies indicate that specialists often do not know the
recommended surveillance interval [9, 10] and those
who are aware of the recommendations often do not
follow them [11].
Efforts to increase adherence to guidelines
Despite evidence of variable adherence to surveillance
colonoscopy guidelines [1, 6, 7], there has been little re-
search on interventions to promote adherence to guide-
lines for CRC follow up. There have, however, been
some evaluations of strategies designed to improve ad-
herence to surveillance colonoscopy in non-cancer sam-
ples (e.g. post polypectomy). For example, an
improvement in guideline adherence was demonstrated
at a single site following dissemination of guidelines to
all specialists and implementation of a nurse co-
ordinator role to ensure that surveillance recommenda-
tions matched guidelines [5]. Physician reminders were
shown to increase surveillance colonoscopy adherence
following adenoma removal in a randomised controlled
trial (RCT) involving 358 patients [12].Given the limited research on interventions to pro-
mote adherence to surveillance colonoscopy recommen-
dations, we aimed to investigate the impact of a
centrally delivered paper-based intervention to improve
adherence to surveillance colonoscopy recommendations
following curative resection for CRC. The intervention
approach selected was designed to be low cost, and have
potential for broad reach to the entire affected popula-
tion, rather than being focussed on a particular health
care service.
Aims
The aim of the study was 1) to determine the effective-
ness of a print-based intervention to increase the pro-
portion of CRC patients who undertake surveillance
tests in line with NHMRC recommendations in the year
following the intervention; and 2) to examine socio-
demographic characteristics and disease characteristics
associated with appropriate screening of CRC patients.
Methods
Setting and approvals
Participants were identified through a population-based
cancer registry in Victoria, Australia. Ethical approvals
were obtained from the University of Newcastle (H-
2008-0047) and the Cancer Council Victoria’s Human
Research Ethics Committees (HREC-0810) and written in-
formed consent was obtained from all participants. Data
were collected between February 2010 and November
2012. This study was part of a larger trial in which people
with CRC were able to invite their first degree relatives to
participate in a study of adherence to CRC screening
among first degree relatives [13]. Only results related to
index cases are reported here.
Participants
People with CRC were invited to participate if they met
the following criteria: 1) aged 18 or older; 2) within
10 months of a primary invasive CRC diagnosis regis-
tered with the cancer registry (ICD-10: C18, C19 and
C20); 3) considered able to participate by their clinician
and 4) sufficiently fluent in English to complete and
understand the consent form and study surveys. Only
those participants who completed a baseline interview
within 12 months of diagnosis, had surgery for CRC and
did not have Stage IV cancer were included in this study.
Procedure
The recruitment process is shown in Fig. 1. A letter was
sent to the notifying clinician of each potentially eligible
person identified by the registry. Clinicians were asked
to advise the registry within a month if the patient was
unsuitable to be approached. Eligible patients were then
invited by the registry to provide written consent for
Fig. 1 Flowchart of recruitment of index cases (IC) to the study
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who agreed were mailed an invitation to participate in
the trial. Up to two reminder letters were sent after four
weeks to non-responders.
Participants were randomised to either the interven-
tion or control group using a centrally-managed
computer-generated randomisation procedure.
Participants completed a baseline computer-assisted
telephone interview (CATI; Additional file 1) and were
asked to provide contact details for their general practi-
tioner and/or specialist (surgeon, oncologist and/or gas-
troenterologists). A paper and pencil follow up survey
(Additional file 2) was sent to participants 12 months after
the baseline interview. Up to two reminder surveys were
sent to those who had not responded within 4 weeks.
Experimental groups
Control
Following the baseline interview, participants rando-
mised to the control group were mailed a generic
pamphlet on CRC.Intervention
Participants randomised to the intervention group re-
ceived a letter detailing recommendations for follow-up
care. The letter highlighted NHMRC [3] recommenda-
tions: 1) to visit a doctor every 3–6 months for 2 years
after surgery; 2) that most patients will need to have a
colonoscopy every 3–5 years. However those who did
not have a complete colonoscopy when first diagnosed
should have one 3–6 months after surgery; 3) a sigmoid-
oscopy may be arranged if the cancer was in the rectum;
and 4) other tests may be scheduled including blood
tests and Computed Tomography (CT) scans. The pa-
tient’s nominated general practitioner and cancer spe-
cialist were also sent a fact sheet with information about
best evidence surveillance care.
Measures
The following data were collected at baseline: 1) Registry
data: Diagnosis date, age at diagnosis, sex, postcode,
cancer type and cancer staging were provided by the
registry for each consenting participants. Grouped de-
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non-consenters to allow assessment of consent bias; 2)
Sociodemographic characteristics: Participants self- re-
ported their age, marital status, highest level of educa-
tion, employment, health insurance status; 3) Cancer
treatments: Participants were asked whether they had
surgery for bowel cancer and when their surgery was
performed; 4) Participation in bowel cancer tests: partici-
pants were asked whether they had ever had one of the
following tests for bowel cancer: colonoscopy, Faecal
Occult Blood Test (FOBT), or sigmoidoscopy. Brief de-
scriptions of each test were provided to aid accurate re-
call. Those who responded affirmatively were asked
additional questions about the timing of their most re-
cent test. Response options included: 1, 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12 months ago, 1–2 years ago, 2–5 years ago,
over 5 years ago.
At 12 months follow up, participants were asked to
provide self-reported data on how many times in the
past year they had seen their cancer specialist and gen-
eral practitioner for bowel cancer follow up care,
whether they had a colonoscopy/FOBT/sigmoidoscopy
and if so in which month they had the test.
Primary outcome: adherence to surveillance guidelines
for colonoscopy
Self-report data on colonoscopy was used to assess adher-
ence. We allowed 1 month leeway to have the procedure.
Participants were considered adherent to surveillance
guidelines if they reported having a colonoscopy at any
time from four months prior to their diagnosis date up to
8 months after their surgery date; otherwise they were clas-
sified as not adherent. Those classified as non-adherent
were considered underscreened if they reported no colon-
oscopies in this period or overscreened if they reported a
subsequent colonoscopy up to 2 years after diagnosis.
Statistical methods
Participant demographic and disease characteristics are
presented for the control and intervention groups. The
primary outcome, adherence to surveillance guidelines
at 12 months follow up, was compared between the con-
trol and intervention groups using a chi-squared test.
The primary analysis was performed as a complete case
analysis, with sensitivity analyses using multiple imput-
ation for missing data. Imputation was undertaken with
20 datasets using a separate monotone imputation
model for the intervention and control groups which in-
cluded the variables age category, sex, rurality, educa-
tion, employment, whether Australian born, relationship
status, insurance status, cancer stage (TNM), cancer site
and timing of most recent colonoscopy recorded in the
baseline interview to impute adherence at follow up and
follow up specialist visits. Estimates were then obtainedusing Rubin’s rules [14]. A logistic regression model was
used to examine the characteristics associated with ad-
herence to surveillance guidelines compared to those
who were not adherent, while adjusting for potential
confounders. The factors included in the model were
age, sex, location, Australian born, education, employ-
ment, private health insurance, cancer location, cancer
stage and follow-up specialist visits. This analysis was
also undertaken on the multiple imputed data. Analyses
were conducted in Stata 11.2 [15].
Assuming 50% adherence in the control group, a loss
to followup of 20%, and a 5% significance level, a sample
of 1200 patients (600 per group) would have at least 80%
power to detect a difference in adherence of 10% be-
tween groups at 12 month follow up (this was consid-
ered to be a clinically important effect).
Effect of guideline change
New guidelines for surveillance colonoscopy were intro-
duced in December 2011 [4] recommending that colon-
oscopy should be performed one year after curative
resection for CRC, unless a complete post-operative col-
onoscopy has been performed sooner. When these
guidelines were released, all intervention materials had
been sent out to the intervention participants, however,
some participants had not yet completed the 12 month
follow up survey. To enable a post hoc investigation of
the adoption of the new guidelines we compared the
proportion of participants who reported having a colon-
oscopy in the follow up period among those who com-
pleted the follow up survey before 31st December 2011
and those who returned the survey after 30 March 2012,
using the Chi-squared test (Those returning a follow up
survey in January to February 2012 were excluded from
the analysis in order to provide a bedding down period
between the two sets of guidelines). We calculated ad-
herence to the new guidelines (colonoscopy in the year
following surgery) for the entire sample. We have pro-
vided examples of how adherence status would be classi-
fied using the old and new guidelines in Table 1.
Results
Sample characteristics
From 3193 people with CRC identified by the registry,
168 were considered ineligible by their notifying clini-
cians, 672 did not provide consent to be contacted by
the research team, 43 were deceased, 54 were ineligible
and 1172 did not respond (see Fig. 1). Of the remaining
1084 who were approached to participate in the study,
752 (69%; 25% of eligible individuals) consented to par-
ticipate and completed the baseline interview. After re-
moving those who did not have surgery, had Stage IV
cancer or did not complete the baseline interview within
a year of being diagnosed, the sample consisted of 604
Table 1 Comparison of adherence classification using the old and new guidelines
Guidelines recommendations
Examples Old guidelines:
Colonoscopy that visualises the entire colon
should be performed at the time of diagnosisa.
If this is not possible, colonoscopy should be
performed within 3–6 months of surgery.
Colonoscopy should be performed 3–5 years after
surgery.
New guidelines:
Colonoscopy should be performed
one year after the resection, unless a
complete post-operative colonoscopy
has been performed sooner.
Classification of adherence
Colonoscopy at diagnosis; no
colonoscopy reported at 12 month
follow up
Adherent Non-adherent
Colonoscopy at diagnosis; followed
by colonoscopy 12 months later
Non-adherent Adherent
Colonoscopy at diagnosis, and then
another colonoscopy within
6 months of surgery
Adherent Adherent
Colonoscopy 6 months post surgery;
no subsequent colonoscopy
reported at 12 month follow up
Adherent Adherent
Colonoscopy 6 months post surgery;
subsequent colonoscopy reported at
12 month follow up
Non-adherent Non-adherent
aWe were unable to tell if the colonoscopy performed at diagnosis visualised the entire colon. Therefore, any cases where this criteria was crucial to determining
adherence were classified as adherent. For example if a colonoscopy was performed at baseline and then again at 6 months, we assumed that the diagnostic
colonoscopy did not enable visualisation of the entire colon, and therefore classified the patient as adherent
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vention group and 299 to the control group. The charac-
teristics of the sample are shown in Table 2 and appear
similar for the two groups. 503 (83%) participants
returned a follow up survey sent out 1 year after the
baseline survey (257, 84% in the intervention group and
246, 82% in the control group). The follow up surveys
were returned up to 3 years from diagnosis.
Primary outcome: adherence to surveillance colonoscopy
guidelines
There was no significant difference between those adher-
ent to surveillance colonoscopy guidelines, in the control
(67, 27%) and intervention groups (80, 31%) at followup
(difference = 4.3% (95%CI: -3.7%, 12%), χ2(1df ) = 1.09, P
= 0.296; Table 3). This result did not change under a
multiple Imputation model for missing outcome data
(Odds ratio = 1.25 (0.86, 1.81); P = 0.234). Table 3 shows
the proportion of participants adherent to guidelines at
followup, under screened and over screened in the con-
trol and intervention groups. Overall in the 1–3 years
following surgery for CRC, 147 (29%) participants re-
ported receiving surveillance colonoscopies in line with
guidelines (118 (24%) perioperatively, 29 (5.8%) up to
8 months since surgery); 27 (5.4%) were underscreened
(16 (3.2%) reported a colonoscopy outside of the recom-
mended time frame and 11 (2.2%) reported not having
any colonoscopies) and 326 (65%) had more colonos-
copies than was recommended (over screened). Themajority of overscreening was due to having a colonos-
copy at diagnosis, followed by another within 12 to
14 months (n = 197; 39%). This pattern of overscreening
is consistent with the new guideline recommendations.
Characteristics associated with adherence
Table 4 shows the results of multiple logistic regression of
factors associated with adherence at follow up compared
to non-adherence. Participants had higher odds of being
adherent to surveillance recommendations if they had a
left-sided tumour relative to a transverse or right sided
tumour; did not see a specialist for follow up care relative
to those who did; or were over 80 compared with younger
age groups. Sensitivity analysis using multiple imputation
provided similar results to complete case analysis.
Effect of guideline change
Overall, 246 (49%) participants were adherent to the
new guidelines, compared to only 147(29%) who were
adherent to the old guidelines. According to the new
guidelines, 24 (4.8%) were overscreened and 230 (46%)
were underscreened. Those who returned a follow up
survey after the guideline change (n = 164) were signifi-
cantly more likely to have had a colonoscopy in the fol-
low up period (124, 76%) than those who returned a
follow up survey prior (n = 180) to the guideline change
(117, 65%) (χ2(1df ) = 4.61; P = 0.032) excluding those
who returned a follow up survey between Dec 2011 and
March 2012 (n = 159).
Table 2 Characteristics of the sample
Variable Control Intervention
N = 299 N = 305
n (%) n (%)
Age (n = 653) Mean = 66 (SD = 11) Mean = 68 (SD = 12)
under 50 16 (5%) 18 (6%)
50–59 60 (20%) 55 (18%)
60–69 98 (33%) 83 (27%)
70–79 85 (28%) 81 (27%)
over 80 40 (13%) 68 (22%)
Male (n = 653) 171 (57%) 154 (50%)
Married/defacto (n = 653) 230 (77%) 205 (67%)
Born in Australia (n = 591) 205 (77%) 223 (80%)
Urban dwelling (n = 652) 202 (68%) 194 (64%)
Education (n = 651)
University or vocational training 99 (33%) 200 (33%)
Secondary school completed 44 (14%) 87 (14%)
Secondary school not completed 161 (53%) 315 (52%)
Employed (n = 653) 106 (32%) 98 (34%)
Private health insurance (n = 653) 197 (66%) 201 (66%)
Previous cancer diagnosis (n = 652) 33 (11%) 54 (18%)
Left-sided tumour (n = 649) 177 (59%) 162 (54%)
Disease stage (n = 652)
TNM Stage I 95 (32%) 98 (33%)
TNM Stage II 100 (34%) 115 (38%)
TNM Stage III 99 (34%) 88 (29%)
Returned a follow up survey (n = 653) 246 (82%) 257 (84%)
Died in follow-up period 11 (4%) 7 (2%)
Days between diagnosis and Intervention (n = 653) Median = 219 (IQR:171-281) Median = 226 (IQR:189-281)
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Our intervention had no impact on adherence to CRC
surveillance colonoscopies. In contrast, previous studies
have indicated that more intensive approaches targeting
clinicians via point of care reminders or feedback on
guideline adherence are effective at improving adherence
[5, 12]. Behavioural change theories indicate that there
are a range of factors that can influence adoption ofTable 3 Adherence to surveillance guidelines in the










Adherent at follow up 80(32%) 67(27%) 147(29%)
Non-adherent at follow up 174(69%) 179(73%) 353(71%)
Under screened 10(3.9%) 17(6.9%) 27(5.4%)
Over screened 164(65%) 162(66%) 326(65%)evidence in clinical practice. These include knowledge,
skills and beliefs, professional role and identity, environ-
mental context and resources, memory and attentional,
social factors, emotion and goal setting [16]. Complex
behaviours, for example, lifestyle changes such as quit-
ting smoking or changing one’s diet are likely to require
complex interventions which target a range of these fac-
tors. In the case of one-off or intermittent behaviours
such as participation in cancer screening simpler inter-
ventions such as mail-based invitations have been shown
to be effective [17]. Therefore, on face value it seems
that a simple mail-based intervention could be effective
for improving adherence to colorectal cancer surveil-
lance colonoscopy recommendations. However, there are
several factors that may explain why this type of inter-
vention is often effective at promoting cancer screening
uptake but was not effective at improving surveillance
adherence. First, our study did not seek to improve up-
take of surveillance colonoscopy but rather to improve
Table 4 Multiple logistic regression of factors associated with adherence to surveillance guidelines at follow up compared to those




Odds ratio P value*
(95% CI)
Experimental group
Control 55 (26%) REF
Intervention 66 (29%) 1.01 (0.64–1.6) 0.954
Age
under 50 3 (14%) 0.44 (0.11–1.83)
50–59 14 (17%) 0.56 (0.24–1.34)
60–69 31 (22%) 0.77 (0.42–1.4)
70–79 39 (31%) REF
over 80 34 (47%) 2 (1.05–3.98) 0.049
Sex
Male 68 (29%) REF
Female 53 (26%) 0.91 (0.56–1.47) 0.697
Highest level of education
University or vocational training 34 (22%) REF
Secondary school completed 23 (34%) 1.6 (0.8–3.12)
Secondary school not completed 64 (29%) 1.03 (0.6–1.77) 0.367
Relationship status
Single 36 (33%) REF
Married/defacto 85 (26%) 1.01 (0.58–1.76) 0.97
Employment status
Not employed 95 (33%) REF
Employed 26 (17%) 0.58 (0.3–1.12) 0.107
Australian born
No 24 (26%) REF
Yes 97 (28%) 1.2 (0.68–2.14) 0.519
Location or residence
Rural 52 (34%) REF
Urban 69 (24%) 0.65 (0.4–1.05) 0.081
Private health insurance
No 44 (34%) REF
Yes 77 (25%) 0.81 (0.49–1.33) 0.406
Disease stage
TNM Stage I 45 (31%) REF
TNM Stage II 44 (27%) 0.67 (0.39–1.16)
TNM Stage III 32 (24%) 0.76 (0.43–1.36) 0.349
Cancer site
Right sided 45 (24%) REF
left-sided 76 (30%) 1.8 (1.13–3.02) 0.014
Saw specialist for follow up care
No 14 (61%) REF
Yes 107 (26%) 0.35 (0.14–0.91) 0.031
* P value for adjusted Wald test
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because this is largely consistent with the beliefs of pa-
tients regarding early detection being beneficial. In con-
trast, reducing the use of surveillance tests may create
anxiety about a potential recurrence being missed [18].
Similarly, clinicians may have concerns about missing a
recurrence and /or may be motivated to reassure pa-
tients through the ordering of such tests.
Therefore, it is possible that our paper- based inter-
vention was not intensive enough and did not adequately
address these barriers. Of further concern, the low par-
ticipation rates (25%) indicate that the approach used,
regardless of effect, is unlikely to be a feasible method to
reach the target group.
Early guideline adoption?
Our post hoc analyses showed that a significantly greater
proportion of respondents were adherent to the new
guidelines (49%) compared to the guidelines that were
current during the majority of the study period (29%).
This is despite the fact that the latter guideline recom-
mendations had been in place for over 10 years at the
time our study commenced [1, 3]. At the time our study
was being implemented, it is possible that some clini-
cians were aware of the planned changes to the guide-
lines and had already adapted their practice to suit these.
A prior Australian study examining guideline adherence
to surveillance colonoscopy between 1989 and 2001 also
demonstrated poor adherence to guideline recommenda-
tions. Most notably the rate of adherence increased from
20% to just 23% following the initial release of the guide-
lines in 1999. Similar to our study, overscreening (i.e. re-
ceiving surveillance colonoscopy too early) was the most
common reason for nonadherence [1]. Taken together,
these data suggest that while these guidelines had been
in place for over 10 years, adherence rates remained low.
Given this, it appears that the most likely explanation
for the higher adherence to the new guidelines is that
they were more closely aligned with practice patterns
over the past 20 years.
The proportion of respondents reporting a colonoscopy
in the follow up period of our study increased following
the release of the updated guideline in late 2011. While it
is difficult to compare the adherence rates reported in the
current study with those of Yusoff [1] due to method dif-
ferences, the 20% increase in adherence reported in our
study can be contrasted with only a 3% increase over a
similar time period following the release of the previous
guidelines. Likewise, based on the old guideline recom-
mendations, comparison of the adherence rates reported
in Yusoff ’s data of 23% in 1999–2001 and our data from
2010 to 2012 indicates an increase in adherence of 6%
from 23% to just 29 over this 13 year time period. Again
this rate of change is compared to the 20% change overthe 3 year period of our study, the magnitude and rapidity
of practice change attributable to the change in guideline
recommendations can be appreciated. Prior research has
shown that adoption is more likely to occur when recom-
mendations are aligned with existing beliefs [19]. Indeed,
this rapid change of practice suggests that the new recom-
mendations are more consistent with clinicians’ beliefs re-
garding best practice.
Limitations
While the participation rates achieved in our study were
similar to those in other studies conducted through can-
cer registries [20, 21], they limit the extent to which our
findings are generalizable to the broader population of
people with CRC. Further, the overall sample size ob-
tained was lower than anticipated resulting in reduced
statistical power, which was not completely compensated
for by lower than expected adherence in the control
group. Post hoc power analysis suggests that we would
have had 80% power to detect approximately 12.5% dif-
ference in adherence between groups.
We relied on patient self-reported colonoscopy use
and timing, so it is possible that the data were subject to
biases in recall and/ or social desirability. Self-reporting
on when a colonoscopy was done may have been par-
ticularly problematic for some participants in the study.
Unfortunately, accessing medical records data or Medi-
care (claims) data was not considered feasible for a
population study such as ours given the number of dif-
ferent health care providers involved in the care of the
patients, and inconsistent availability of Medicare data
depending upon treatment setting. We did not collect
detailed information about current treatment or disease
progression therefore it is possible that for some people
in the sample the surveillance guidelines may not have
been appropriate. We excluded those with Stage IV can-
cer to limit the effect of this. At the commencement of
our study, we did not anticipate the guideline change,
and so did not collect additional data on clinician beliefs
to aid in our interpretation of the factors influencing the
practice patterns observed.
Conclusions
Our results indicate that a paper-based educational
intervention aimed at patients and surgeons is not ef-
fective in improving adherence to CRC surveillance
guidelines for colonoscopy. Notwithstanding recent
changes to the guideline recommendations regarding the
timing of colonoscopy, poor adherence to surveillance
colonoscopy recommendations was observed. However,
higher rate of adherence to the new guideline recom-
mendations released during our study, suggests that the
new guidelines are more consistent with existing prac-
tice patterns.
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Additional file 1: Interview Guide for computer-assisted telephone
interview (CATI) completed by participants at baseline. Description:
Questions from the baseline CATI guide used in the research presented.
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Additional file 2: Follow up survey sent to participants 12 months after
the baseline interview. Description: Questions from the pen and paper
follow up survey used in the research presented. (PDF 24 kb)
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